Navigation Links
Kendle Leaders Adopt 10b5-1 Trading Plans
Date:3/7/2008

eriod of time to reduce market impact, and avoid concerns about transactions occurring at a time when they might possess inside information.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
2. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
3. Kendle to Present at the Wachovia 2008 Healthcare Conference
4. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
5. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
6. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
7. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
8. Kendle to Present at the UBS Global Life Sciences Conference
9. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
10. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...- Aegera Therapeutics Inc. announced today the dos...study of AEG35156, a targeted antisense therapeuti...ndications. ,, The study, entitled "An Open-Lab...tor of Apoptosis (XIAP) Antisense AEG35156 Given i...icin in AML Following Failure of a Single Standard...
(Date:11/18/2009)...re/ -- Marrone Bio Innovations (MBI), a leader in ...f effective and environmentally responsible pest m...ed an IC20 company by the Investors, Circle, the U...vesting group. ,, Companies named to the IC20 e...or all stakeholders, including investors, the envi...
(Date:11/18/2009)...ewswire-FirstCall/ -- Sangamo BioSciences, Inc. (N...University of Pennsylvania investigator sponsored ...ease (ZFN) based product, SB-728-T, for HIV/AIDS w... internet. ,, Data were presented in a student ... Medicine from a single subject treated with SB-72...
(Date:11/18/2009)...wire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: ...nt company that identifies and advances a diverse ...various stages of development, announced that resu...nted today in a poster at the 2009 AACR-NCI-EORTC ...ce in Boston, Massachusetts. The reported results ...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...echnologies, Inc., a leading,provider of innovativ...elopment and manufacturing, announced today that i...ds, Deloitte LLP,s San Diego Technology Fast 50,an...ng Private Companies,for the fifth consecutive yea...nking of the 50 fastest growing technology, media,...
...nhua-PRNewswire/ -- WuXi PharmaTech,(Cayman) Inc. ...ogy and,medical device research and development ou... United States, today announced the addition of Je...LLC, to the WuXi Board of,Directors. Mr. Leng is r...,on the WuXi board. General Atlantic is a global g...
...d Enzyme Activity Appear Years Younger, PROVO, Ut...nc. (NYSE: NUS ) presented the results of a break... of Societies of Cosmetic Chemists,Congress (IFSCC...els of a,newly identified age-related enzyme, arNO... at Stanford University, demonstrated that women w...
Other Biology Technology:Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year 2WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors 2Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 2Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator 3
(Date:11/19/2009)...identified thousands of diverse genes in genetical...ques may allow breeders and researchers to use thi...nd create new varieties that were not easily possi... Science , the researchers, whose senior and firs... map of haplotypes sets of closely linked gene va...
(Date:11/19/2009)...NIH Director,s T-R01 Award , Speedier Lab Testing...Jaffrey, associate professor of pharmacology at We...searchers to win a prestigious NIH Director,s Tran...of Health. Dr. Jaffrey and his colleagues are deve... that may some day speed up lab testing by instant...
(Date:11/19/2009)...onsume a highly endangered species, doing so might...w genetic detective work from the Sackler Institut...of Natural History shows that bluefin tuna is rout... Colorado. A quarter of what was labeled as tuna o...ar, a waxy, buttery fish often labeled "white tuna...
Breaking Biology News(10 mins):New map of variation in maize genetics holds promise for developing new varieties 2Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Unknowlingly consuming endangered tuna 2Unknowlingly consuming endangered tuna 3Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 1Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 2Research network wins approximately 26 23163 3B5 7 million to target human and animal diseases in Africa 9092 3New Study Shows Many Unplanned Quit Smoking Attempts are Successful 50605 1New Study Shows Many Unplanned Quit Smoking Attempts are Successful 50605 2Portico Healthnet Assumes Operation of 489 CARE Information and Referral Service 50603 1Portico Healthnet Assumes Operation of 489 CARE Information and Referral Service 50603 2
...zed, with specialized areas for different function.... Researchers from the University of Illinois, Chi...irst imaging evidence from live cells of ongoing o... , Genes that are active are located mainly in th...nes are at the periphery. But scientists have had ...
...o universities may lead to new directions in cance...hat a genetic switch involved in growth and develo... normal cells from becoming cancerous. , The findi...Biology. Experiments were carried out by first aut...orking in the laboratories of Joel H. Rothman, a p...
... Medical School have discovered a new population o...operties of primitive stem cells. , Umbilical co...ic stem cells that can only produce cells found in...ll population of cord blood cells with the charact...e potential to produce a greater variety of cell t...
Other Biology News:Movement of chromosome in nucleus visualized 2Movement of chromosome in nucleus visualized 3Scientists discover a genetic switch that links animal growth and cancer 2
... the 9, 10, 12, and 13 positions. It is intended f...ion of 13(S)-HODE by GC- or LC-mass spectrometry. ...cid with plant and mammalian lipoxygenases. It has... to the endothelium at concentrations around 1 &#x...
pcDNA4/His A B & C from Invitrogen
Adaptor Hind III - Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
Biology Products: